Eliem Therapeutics, Inc. Contracts & Agreements

46 Contracts & Agreements
Browse by Contract Category
Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Equity Distribution Agreement, dated as of March 25, 2025, by and between Climb Bio, Inc. and Oppenheimer & Co. Inc
Eliem Therapeutics, Inc.
Biotechnology
2025
Technology Transfer and Exclusive License Agreement, dated January 8, 2025, by and between the Registrant and Beijing Mabworks Biotech Co., Ltd
Eliem Therapeutics, Inc.
Biotechnology
2025
2021 Employee Stock Purchase Plan
Eliem Therapeutics, Inc.
Biotechnology
2025
Forms of Restricted Stock Unit Grant Notice and Restricted Stock Unit Award Agreement under the 2021 Equity Incentive Plan
Eliem Therapeutics, Inc.
Biotechnology
2025
Forms of Option Agreement, Stock Option Grant Notice and Notice of Exercise under the 2021 Equity Incentive Plan
Eliem Therapeutics, Inc.
Biotechnology
2025
2021 Equity Incentive Plan
Eliem Therapeutics, Inc.
Biotechnology
2025
Description of Securities
Eliem Therapeutics, Inc.
Biotechnology
2025
Form of common stock certificate of the Registrant
Stock Agreements
Eliem Therapeutics, Inc.
Biotechnology
2025
Amendment to Consulting Agreement, dated November 1, 2024, between Registrant and Stephen Thomas
Consulting Agreements
Eliem Therapeutics, Inc.
Biotechnology
2024
Consulting Agreement, dated June 27, 2024, between the Registrant and Stephen Thomas
Consulting Agreements
Eliem Therapeutics, Inc.
Biotechnology
DE
2024
Settlement Agreement, dated August 23, 2024, between Eliem Therapeutics, Inc. and Valerie Morisset, Ph.D
Settlement Agreements
Eliem Therapeutics, Inc.
Biotechnology
2024
Offer Letter, dated July 31, 2024, between Eliem Therapeutics, Inc. and Brett Kaplan, M.D
Eliem Therapeutics, Inc.
Biotechnology
2024
Cell Line Development, Manufacturing Services and License Agreement, effective as of February 9, 2021, by and between ValenzaBio, Inc. and ProBioGen, Inc
License Agreements
Eliem Therapeutics, Inc.
Biotechnology
2024
Amended and Restated License Agreement, dated as of January 11, 2024, by and between Tenet Medicines, Inc. and Cancer Research Technology Limited
License Agreements
Eliem Therapeutics, Inc.
Biotechnology
DE
2024
Asset Purchase Agreement, dated as of January 11, 2024, by and between Tenet Medicines, Inc., Acelyrin, Inc. and WH2, LLC
Purchase Agreements
Eliem Therapeutics, Inc.
Biotechnology
DE
2024
Offer Letter, dated June 12, 2024, between Eliem and Aoife Brennan
Eliem Therapeutics, Inc.
Biotechnology
2024
Senior Secured Promissory Note, dated as of May 14, 2024, between Eliem Therapeutics, Inc. and Tenet Medicines, Inc
Eliem Therapeutics, Inc.
Biotechnology
DE
2024
Agreement and Plan of Merger and Reorganization, dated as of April 10, 2024, by and among Eliem Therapeutics, Inc., Tango Merger Sub, Inc., Tenet Medicines, Inc. and, solely in...
Merger Agreements
Eliem Therapeutics, Inc.
Biotechnology
DE
2024
Registration Rights Agreement, dated April 10, 2024, by and among Eliem Therapeutics, Inc. and the persons party thereto
Registration Rights Agreements
Eliem Therapeutics, Inc.
Biotechnology
NY
2024
Securities Purchase Agreement, dated April 10, 2024, by and among Eliem Therapeutics, Inc. and the persons party thereto
Purchase Agreements
Eliem Therapeutics, Inc.
Biotechnology
NY
2024
Form of Lock-Up Agreement
Eliem Therapeutics, Inc.
Biotechnology
2024
Form of Tenet Support and Joinder Agreement
Joinder Agreements
Eliem Therapeutics, Inc.
Biotechnology
DE
2024
Form of Company Support Agreement
Eliem Therapeutics, Inc.
Biotechnology
DE
2024
Separation and Consulting Agreement, dated February 13, 2023, by and between Eliem Therapeutics, Inc. and James B. Bucher
Consulting Agreements
Eliem Therapeutics, Inc.
Biotechnology
2024
Executive Employment Agreement by and between the Eliem Therapeutics, Inc. and James B. Bucher, effective October 1, 2020
Employment Agreements
Eliem Therapeutics, Inc.
Biotechnology
WA
2024
Separation and Consulting Agreement, dated February 13, 2023, by and between Eliem Therapeutics, Inc. and Erin Lavelle
Consulting Agreements
Eliem Therapeutics, Inc.
Biotechnology
2023
Separation and Consulting Agreement, dated February 13, 2023, by and between Eliem Therapeutics, Inc. and Robert Azelby
Consulting Agreements
Eliem Therapeutics, Inc.
Biotechnology
2023
Description of Securities
Eliem Therapeutics, Inc.
Biotechnology
2022
Forms of Option Agreement, Stock Option Grant Notice and Notice of Exercise under the 2021 Equity Incentive Plan
Bonus & Incentive Agreements
Eliem Therapeutics, Inc.
Biotechnology
DE
2021
Form of Underwriting Agreement
Underwriting Agreements
Eliem Therapeutics, Inc.
Biotechnology
NY
2021
Form of common stock certificate of the Registrant
Stock Agreements
Eliem Therapeutics, Inc.
Biotechnology
2021
Forms of Option Agreement and Notice of Exercise under the 2019 Equity Incentive Plan
Bonus & Incentive Agreements
Eliem Therapeutics, Inc.
Biotechnology
2021
2021 Equity Incentive Plan
Bonus & Incentive Agreements
Eliem Therapeutics, Inc.
Biotechnology
DE
2021
Forms of Restricted Stock Unit Grant Notice and Restricted Stock Unit Award Agreement under the 2021 Equity Incentive Plan
Bonus & Incentive Agreements
Eliem Therapeutics, Inc.
Biotechnology
DE
2021
2021 Employee Stock Purchase Plan
Stock Agreements
Eliem Therapeutics, Inc.
Biotechnology
NY
2021
Form of Indemnification Agreement, by and between the Registrant and each of its directors and executive officers
Indemnification Agreements
Eliem Therapeutics, Inc.
Biotechnology
DE
2021
Executive Employment Agreement by and between the Registrant and Bob Azelby, effective October 1, 2021, as amended
Employment Agreements
Eliem Therapeutics, Inc.
Biotechnology
WA
2021
Executive Employment Agreement by and between the Registrant and Erin M. Lavelle, effective October 1, 2021, as amended
Employment Agreements
Eliem Therapeutics, Inc.
Biotechnology
WA
2021
Unit Transfer Agreement, dated February 4, 2019, by and between the Registrant and the Members of NeoKera, LLC
Eliem Therapeutics, Inc.
Biotechnology
DE
2021
Executive Employment Agreement by and between Eliem Therapeutics (UK) Ltd. and Valerie Morisset, Ph.D., effective January 1, 2021
Employment Agreements
Eliem Therapeutics, Inc.
Biotechnology
WA
2021
Executive Employment Agreement by and between the Registrant and Erin M. Lavelle, effective October 1, 2021
Employment Agreements
Eliem Therapeutics, Inc.
Biotechnology
WA
2021
Executive Employment Agreement by and between the Registrant and Bob Azelby, effective October 1, 2021
Employment Agreements
Eliem Therapeutics, Inc.
Biotechnology
WA
2021
2019 Equity Incentive Plan, as amended
Bonus & Incentive Agreements
Eliem Therapeutics, Inc.
Biotechnology
CA
2021
Amended and Restated Investor Rights Agreement, dated May 21, 2021, by and among the Registrant and the investors listed on Schedule A thereto
Investor Rights Agreements
Eliem Therapeutics, Inc.
Biotechnology
DE
2021
Agreement and Plan of Merger and Reorganization, dated October 15, 2020, by and among the Registrant, Athena Merger Sub Inc., Athenen Therapeutics, Inc., AI ETI LLC, as Eliem...
Merger Agreements
Eliem Therapeutics, Inc.
Biotechnology
DE
2021
Asset Contribution Agreement, dated February 4, 2019, by and between the Registrant and Carnot, LLC
Contribution Agreements
Eliem Therapeutics, Inc.
Biotechnology
2021